Enantioes Bio & Chemicals Private Limited - Company Profile

It is a chemicals private limited company based in Hyderabad, Telangana, India, established in 2008.
2008 Hyderabad, Telangana, India Struck Off
Last Updated:
Access Report
About Enantioes Bio & Chemicals Private Limited

Enantioes Bio & Chemicals Private Limited, a struck off private limited company, was established on 01 January 2008 in Hyderabad, Telangana, India. Engaging in industrial chemicals within the chemicals sector, it holds CIN: U24232TG2008PTC056904. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M.

Its leadership includes Kishore Sunkara (Director), Mukkanti Amere (Director), Satyanarayana Tummanapalli (Director). It is based at 3-10-20/34/G1, Sai Krupa Nivas, Gokhale Nagar, Ramantha Pur, Hyderabad, Telangana, 500013.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TG2008PTC056904

  • Registration Number

    056904

  • Incorporation Date

    01 January 2008

  • Authorized Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Company Age 18 Year, 1 Month
Company report

Enantioes Bio & Chemicals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Enantioes Bio & Chemicals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Enantioes Bio & Chemicals Private Limited?
Current Directors
Name Designation Appointment Date Status
Kishore Sunkara Director 01 Jan 2008 Current
Mukkanti Amere Director 01 Jan 2008 Current
Satyanarayana Tummanapalli Director 01 Jan 2008 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Enantioes Bio & Chemicals.

Enhance accessibility to Enantioes Bio & Chemicals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Enantioes Bio & Chemicals revenue growth over time
Enantioes Bio & Chemicals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Enantioes Bio & Chemicals?

Unlock access to Enantioes Bio & Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Enantioes Bio & Chemicals?

Unlock and access historical data on people associated with Enantioes Bio & Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Enantioes Bio & Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enantioes Bio & Chemicals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Enantioes Bio & Chemicals
Recent Activity within the Organization
  • Director Appointment

    Progress on Kishore Sunkara was appointed as a Director was appointed as a Director on 01 Jan 2008 & has been associated with this company since 18 years 1 month . was documented.

  • Director Appointment

    Progress on Mukkanti Amere was appointed as a Director was appointed as a Director on 01 Jan 2008 & has been associated with this company since 18 years 1 month . was documented.

  • Director Appointment

    Progress on Satyanarayana Tummanapalli was appointed as a Director was appointed as a Director on 01 Jan 2008 & has been associated with this company since 18 years 1 month . was documented.

  • Company Incorporation

    Enantioes Bio & Chemicals Private Limited was registered on 01 Jan 2008 with Roc Hyderabad & aged 18 years 1 month as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Enantioes Bio & Chemicals Private Limited?

The CIN of Enantioes Bio & Chemicals Private Limited is U24232TG2008PTC056904.

Where is Enantioes Bio & Chemicals Private Limited headquartered?

Enantioes Bio & Chemicals Private Limited is headquartered at 3-10-20/34/G1, Sai Krupa Nivas, Gokhale Nagar, Ramantha Pur, Hyderabad, Telangana, 500013.

When was Enantioes Bio & Chemicals Private Limited incorporated?

Enantioes Bio & Chemicals Private Limited was incorporated on 01 January 2008.

Who are the current directors of Enantioes Bio & Chemicals Private Limited?

The current directors of Enantioes Bio & Chemicals Private Limited are

What is the primary industry of Enantioes Bio & Chemicals Private Limited?

The primary industry of Enantioes Bio & Chemicals Private Limited is Chemicals.

Is Enantioes Bio & Chemicals Private Limited a listed company?

Enantioes Bio & Chemicals Private Limited is unlisted.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available